The FTC Is Suing PBMs Over Insulin Prices. Will It Be Successful? - MedCity News
The FTC is suing major pharmacy benefit managers for unfair practices affecting insulin prices and patient access.
FTC sues insulin middlemen, saying they pocket billions while patients face high costs
The FTC is targeting pharmacy benefit managers to address high insulin costs, which have shot up by 600% over two decades, impacting diabetic patients.
FTC goes after drug middlemen for allegedly jacking up insulin prices
The FTC is suing three PBMs for allegedly inflating insulin prices, impacting many Americans reliant on the drug.
The FTC Is Suing PBMs Over Insulin Prices. Will It Be Successful? - MedCity News
The FTC is suing major pharmacy benefit managers for unfair practices affecting insulin prices and patient access.
FTC sues insulin middlemen, saying they pocket billions while patients face high costs
The FTC is targeting pharmacy benefit managers to address high insulin costs, which have shot up by 600% over two decades, impacting diabetic patients.
FTC goes after drug middlemen for allegedly jacking up insulin prices
The FTC is suing three PBMs for allegedly inflating insulin prices, impacting many Americans reliant on the drug.